I have a logging thermometer, a box of insulin syringes and no illusions about my worktop being sterile.
I would like to define my thresholds before I have a result, for obvious reasons.
I want a plan with explicit stopping rules, not just steps.
How do I make this decision on evidence rather than on feel?
Answer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.
Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.
Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.
Inspect before reconstitution. Afterwards you cannot tell whose particle it is.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs to know what you are looking for, because most people inspect vials without a list and therefore see nothing.
Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.
Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.
The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.
Photograph anything unexpected before touching it further.
edited 19 Apr 2026 by laminar_bench — added the placebo-arm figures
The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.
Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.
Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.
Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.
The lot code has to be on the vial. A code on the box ties nothing to anything.
The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.
Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.
Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.
Passing inspection is a weak result. It rules out the obvious and nothing else.
The lot code on the vial, not on the box, is what ties your material to a certificate.
After reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.
Container closure integrity depends on the crimp and stopper seating, which is why those are the first things checked in any incoming-goods inspection.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Crimp, stopper, label, contents. Light background and dark background.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.